BU-NOT-SET

CONTACT US
Fixed dose combinations - for improved patient compliance
  • Drug product
mini-tablets
Fact sheet
The current state of contract manufacturing
  • Industry trends
Eyes
Insight
The potential impact of Brexit on patient safety
  • Industry trends
Eyes
Insight
EU FMD: After the deadline
  • Manufacturing
Eyes
Insight
The importance of supply chain security
  • Manufacturing
Eyes
Insight
ADC development: setbacks and key developments
  • Drug substance
Lab equipment
Insight
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
  • Drug substance
Eyes
Insight
CDMO trends: Drug development and industry consolidation
  • Industry trends
Eyes
Insight
Consolidation in the CDMO Market
  • Industry trends
Eyes
Insight
Insight
  • Drug product
On the pathway to clinic, solubility remains one of the biggest hurdles: CDMO
Insight
  • Manufacturing
US DSCSA: data standardisation
Insight
  • Drug product
Developments in high-throughput screening
Insight
  • Industry trends
CDMOs and innovation: remaining competitive
Insight
  • Industry trends
2018 Forecast: What to watch out for over the coming 12 months in pharma
Insight
  • Manufacturing
Pharmaceutical Manufacturing: one year until the EU FMD
Insight
  • Industry trends
Recipharm’s outlook: The evolution of the CDMO market
Insight
  • Drug product
  • Industry trends
CDMO services: Key drivers of growth
Insight
  • Manufacturing
Preparing for track & trace | pharmaceutical serialization regulations